DRUG (Bright Minds Biosciences) Days Sales Outstanding: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DRUG Bright Minds Biosciences Inc DRUG
34 GF Score
Price $59.46
! 1 Warning Sign
View Full Analysis

What is Bright Minds Biosciences Days Sales Outstanding?

Bright Minds Biosciences's average Accounts Receivable for the three months ended in Jun. 2026 was $0.00 Mil. Bright Minds Biosciences's Revenue for the three months ended in Jun. 2026 was $0.00 Mil.

The historical rank and industry rank for Bright Minds Biosciences's Days Sales Outstanding or its related term are showing as below:

DRUG's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.01
* Ranked among companies with meaningful Days Sales Outstanding only.

Bright Minds Biosciences's Days Sales Outstanding stayed the same from Jun. 2025 () to Jun. 2026 ().

Bright Minds Biosciences  (NAS:DRUG) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bright Minds Biosciences Days Sales Outstanding Related Terms

Bright Minds Biosciences Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Bright Minds Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Minds Biosciences Days Sales Outstanding Chart

Bright Minds Biosciences Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Days Sales Outstanding
Get a 7-Day Free Trial - - - - -

Bright Minds Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DRUG vs VRTX, REGN, MRNA: Days Sales Outstanding Comparison

For the Biotechnology subindustry, Bright Minds Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Minds Biosciences Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's Days Sales Outstanding falls into.


DRUG
34GF Score
Bright Minds Biosciences Inc DRUG
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bright Minds Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bright Minds Biosciences's Days Sales Outstanding for the fiscal year that ended in Sep. 2025 is calculated as

Days Sales Outstanding (A: Sep. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Sep. 2025 )) / count ) / Revenue (A: Sep. 2025 )*Days in Period
=( ( + ) / 1 ) / 0*365
=0 / 0*365
=N/A

Bright Minds Biosciences's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2026 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( ( + ) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Minds Biosciences Business Description

Other Exchanges DRUG:Canada
Address 19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
34GF Score

Get the complete analysis for DRUG

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$59.46
Price